Labiana Health, S.A. (BME:LAB)
Spain · Delayed Price · Currency is EUR 5.50
+0.45 (8.91%)
Last updated: Oct 26, 2026, 4:26 PM CET
Labiana Health Revenue
Labiana Health had revenue of 41.26M EUR in the half year ending June 30, 2026, with 17.57% growth. This brings the company's total for the last twelve months to 77.24M, up 9.76% year-over-year. In the year 2025, Labiana Health had annual revenue of 75.18M with 13.47% growth. That makes Labiana Health the 23,854th largest company in the world by revenue and 116th in Spain.
Revenue (ttm)
77.24M
Revenue Growth
+9.76%
P/S Ratio
0.60
Revenue / Employee
204.94K
Employees
373
Market Cap
45.64M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Labiana Health breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 75.18M | 8.92M | 13.47% |
| Dec 31, 2024 | 66.26M | 7.79M | 13.33% |
| Dec 31, 2023 | 58.46M | 613.91K | 1.06% |
| Dec 31, 2022 | 57.85M | 892.44K | 1.57% |
| Dec 31, 2021 | 56.96M | -883.02K | -1.53% |
| Dec 31, 2020 | 57.84M | 9.62M | 19.96% |
| Dec 31, 2019 | 48.21M | 5.44M | 12.72% |
| Dec 31, 2018 | 42.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.42B |
| Almirall | 1.16B |
| Laboratorios Farmaceuticos Rovi | 773.05M |
| Faes Farma | 711.06M |
| Laboratorio Reig Jofre | 337.73M |
| Prim, S.A. | 250.65M |
| Atrys Health | 147.68M |
| Oryzon Genomics | 15.41M |